Efficacy of autologous platelet rich plasma (PRP) in prevention of hypertrophic scar
Not Applicable
- Conditions
- Keloid and hypertrophic scar.
- Registration Number
- IRCT20201007048955N1
- Lead Sponsor
- Clinical Research Development Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not having diabetes
Not having autoimmune diseases
Not having thrombocytopenia(platelets below 150000)
Not receiving glucocorticoids
Exclusion Criteria
Patient not referring to the doctor for surveillance
Death of the patient during the surveillance period
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hypertrophic scar score. Timepoint: 2nd, 12th and 24th weeks after surgery. Method of measurement: Vancouver scar scale(VSS).
- Secondary Outcome Measures
Name Time Method